Taken together, upregulating VEGFR3 signaling is a potential therapeutic strategy to repair lymphangiogenesis in obesity and adipose-targeted administration of VEGFR3 ligands might be more beneficial than systemic approaches. Here, FLT4 is linked to obesity due to melanocortin 4 receptor deficiency.